Three effective cases of transcatheter arterial embolization after atezolizumab and bevacizumab treatment for hepatocellular carcinoma: a case report
Atezolizumab and bevacizumab followed by transcatheter arterial embolization may be an effective treatment strategy for patients with intermediate-stage hepatocellular carcinoma that is transcatheter-arterial-chemoembolization-refractory or transcatheter-arterial-chemoembolization-unsuitable.
Authors
- Norifumi Kawada (ORCID: https://orcid.org/0000-0002-6392-8311)
- Koji Rinka
- Yuga Amano
- Takashi Nakai
- Kiyohide Kioka
- Yasuko Kawasaki
Institutions
- Osaka City General Hospital (JP)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1186/s13256-025-05040-5
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32